These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33207079)

  • 1. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer.
    Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ
    Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
    Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
    Reis LMD; Adamoski D; Ornitz Oliveira Souza R; Rodrigues Ascenção CF; Sousa de Oliveira KR; Corrêa-da-Silva F; Malta de Sá Patroni F; Meira Dias M; Consonni SR; Mendes de Moraes-Vieira PM; Silber AM; Dias SMG
    J Biol Chem; 2019 Jun; 294(24):9342-9357. PubMed ID: 31040181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity.
    Yu L; Wei W; Lv J; Lu Y; Wang Z; Cai C
    Cancer Lett; 2024 Nov; 604():217271. PubMed ID: 39306229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.
    Lu R; Hong J; Fu T; Zhu Y; Tong R; Ai D; Wang S; Huang Q; Chen C; Zhang Z; Zhang R; Guo H; Li B
    Adv Sci (Weinh); 2024 Jun; 11(24):e2308945. PubMed ID: 38627980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
    Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
    Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Fatty Acid Oxidation Improves Cancer-free Survival in a Mouse Model of Li-Fraumeni Syndrome.
    Wang PY; Ma J; Li J; Starost MF; Wolfgang MJ; Singh K; Pirooznia M; Kang JG; Hwang PM
    Cancer Prev Res (Phila); 2021 Jan; 14(1):31-40. PubMed ID: 32958587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.
    Camarda R; Zhou AY; Kohnz RA; Balakrishnan S; Mahieu C; Anderton B; Eyob H; Kajimura S; Tward A; Krings G; Nomura DK; Goga A
    Nat Med; 2016 Apr; 22(4):427-32. PubMed ID: 26950360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
    Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
    Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.
    Park JH; Vithayathil S; Kumar S; Sung PL; Dobrolecki LE; Putluri V; Bhat VB; Bhowmik SK; Gupta V; Arora K; Wu D; Tsouko E; Zhang Y; Maity S; Donti TR; Graham BH; Frigo DE; Coarfa C; Yotnda P; Putluri N; Sreekumar A; Lewis MT; Creighton CJ; Wong LC; Kaipparettu BA
    Cell Rep; 2016 Mar; 14(9):2154-2165. PubMed ID: 26923594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes.
    Wei J; Yuan Y; Chen L; Xu Y; Zhang Y; Wang Y; Yang Y; Peek CB; Diebold L; Yang Y; Gao B; Jin C; Melo-Cardenas J; Chandel NS; Zhang DD; Pan H; Zhang K; Wang J; He F; Fang D
    Nat Commun; 2018 Sep; 9(1):3659. PubMed ID: 30201971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
    PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein-coupled kisspeptin receptor induces metabolic reprograming and tumorigenesis in estrogen receptor-negative breast cancer.
    Dragan M; Nguyen MU; Guzman S; Goertzen C; Brackstone M; Dhillo WS; Bech PR; Clarke S; Abbara A; Tuck AB; Hess DA; Pine SR; Zong WX; Wondisford FE; Su X; Babwah AV; Bhattacharya M
    Cell Death Dis; 2020 Feb; 11(2):106. PubMed ID: 32034133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression.
    Liu L; Long H; Wu Y; Li H; Dong L; Zhong JL; Liu Z; Yang X; Dai X; Shi L; Ren M; Lin Z
    Cell Signal; 2018 Oct; 50():90-99. PubMed ID: 29958993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirt5 improves cardiomyocytes fatty acid metabolism and ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via CPT2 de-succinylation.
    Wu M; Tan J; Cao Z; Cai Y; Huang Z; Chen Z; He W; Liu X; Jiang Y; Gao Q; Deng B; Wang J; Yuan W; Zhang H; Chen Y
    Redox Biol; 2024 Jul; 73():103184. PubMed ID: 38718533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1.
    Ruidas B; Sur TK; Das Mukhopadhyay C; Sinha K; Som Chaudhury S; Sharma P; Bhowmick S; Majumder R; Saha A
    Breast Cancer; 2022 Jul; 29(4):748-760. PubMed ID: 35511410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
    Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    Aiderus A; Black MA; Dunbier AK
    BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
    Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
    Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.